Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R5MR
|
||||
Former ID |
DNC008676
|
||||
Drug Name |
N4,N6-dibenzylpyrimidine-4,6-dicarboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529830] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H18N4O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CNC(=O)C2=CC(=NC=N2)C(=O)NCC3=CC=CC=C3
|
||||
InChI |
1S/C20H18N4O2/c25-19(21-12-15-7-3-1-4-8-15)17-11-18(24-14-23-17)20(26)22-13-16-9-5-2-6-10-16/h1-11,14H,12-13H2,(H,21,25)(H,22,26)
|
||||
InChIKey |
WIUCYEOLRGUYEH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Collagenase 3 | Target Info | Inhibitor | [529830] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
PANTHER Pathway | Alzheimer disease-presenilin pathway | ||||
Plasminogen activating cascade | |||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.